Literature DB >> 20506031

Antibodies to aquaporin-4 in non-small cell lung cancer: a study on 50 patients.

S Jarius, A Warth, K P Wandinger, P A Schnabel, H Hoffmann, B Wildemann, T Muley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20506031     DOI: 10.1007/s10072-010-0290-9

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  13 in total

1.  The clinical course of neuromyelitis optica (Devic's syndrome).

Authors:  D M Wingerchuk; W F Hogancamp; P C O'Brien; B G Weinshenker
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

2.  A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset.

Authors:  S Nishiyama; T Ito; T Misu; T Takahashi; A Kikuchi; N Suzuki; K Jin; M Aoki; K Fujihara; Y Itoyama
Journal:  Neurology       Date:  2009-06-02       Impact factor: 9.910

3.  Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen.

Authors:  S Jarius; C Probst; K Borowski; D Franciotta; B Wildemann; W Stoecker; K P Wandinger
Journal:  J Neurol Sci       Date:  2010-02-01       Impact factor: 3.181

4.  A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.

Authors:  Vanda A Lennon; Dean M Wingerchuk; Thomas J Kryzer; Sean J Pittock; Claudia F Lucchinetti; Kazuo Fujihara; Ichiro Nakashima; Brian G Weinshenker
Journal:  Lancet       Date:  2004 Dec 11-17       Impact factor: 79.321

5.  Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.

Authors:  Monika Bradl; Tatsuro Misu; Toshiyuki Takahashi; Mitsutoshi Watanabe; Simone Mader; Markus Reindl; Milena Adzemovic; Jan Bauer; Thomas Berger; Kazuo Fujihara; Yasuto Itoyama; Hans Lassmann
Journal:  Ann Neurol       Date:  2009-11       Impact factor: 10.422

6.  Aquaporin-4 autoantibodies in a paraneoplastic context.

Authors:  Sean J Pittock; Vanda A Lennon
Journal:  Arch Neurol       Date:  2008-05

Review 7.  Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.

Authors:  Sven Jarius; Friedemann Paul; Diego Franciotta; Patrick Waters; Frauke Zipp; Reinhard Hohlfeld; Angela Vincent; Brigitte Wildemann
Journal:  Nat Clin Pract Neurol       Date:  2008-03-11

8.  Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies.

Authors:  Grazia Paola Nicchia; Mauro Mastrototaro; Andrea Rossi; Francesco Pisani; Carla Tortorella; Maddalena Ruggieri; Anna Lia; Maria Trojano; Antonio Frigeri; Maria Svelto
Journal:  Glia       Date:  2009-10       Impact factor: 7.452

9.  Neuromyelitis optica: Passive transfer to rats by human immunoglobulin.

Authors:  Makoto Kinoshita; Yuji Nakatsuji; Takashi Kimura; Masayuki Moriya; Kazushiro Takata; Tatsusada Okuno; Atsushi Kumanogoh; Koji Kajiyama; Hiroo Yoshikawa; Saburo Sakoda
Journal:  Biochem Biophys Res Commun       Date:  2009-06-21       Impact factor: 3.575

10.  Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.

Authors:  S Jarius; F Aboul-Enein; P Waters; B Kuenz; A Hauser; T Berger; W Lang; M Reindl; A Vincent; W Kristoferitsch
Journal:  Brain       Date:  2008-10-22       Impact factor: 13.501

View more
  2 in total

1.  Clinical profile of patients with paraneoplastic neuromyelitis optica spectrum disorder and aquaporin-4 antibodies.

Authors:  Maria Sepúlveda; Nuria Sola-Valls; Domingo Escudero; Bojan Rojc; Manuel Barón; Luis Hernández-Echebarría; Begoña Gómez; Josep Dalmau; Albert Saiz; Francesc Graus
Journal:  Mult Scler       Date:  2017-09-18       Impact factor: 6.312

Review 2.  Neuromyelitis optica: clinical features, immunopathogenesis and treatment.

Authors:  S Jarius; B Wildemann; F Paul
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.